Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportClinical Science

18F-FDG PET/MRI and clinical risk factors for early cardiotoxicity induced by anthracycline in patients with malignant tumor

Tingting Yuan, maomao wei, xuetao chen, Xinfeng Lin, Hua Zhu, 志 杨 and xuejuan wang
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 3367;
Tingting Yuan
1Peking University Cancer Hospital & Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
maomao wei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
xuetao chen
1Peking University Cancer Hospital & Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinfeng Lin
2Beijing Cancer Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Zhu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
志 杨
3北京大学肿瘤医院
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
xuejuan wang
1Peking University Cancer Hospital & Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 3367

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Tingting Yuan1,
  2. maomao wei,
  3. xuetao chen1,
  4. Xinfeng Lin2,
  5. Hua Zhu,
  6. 志 杨3 and
  7. xuejuan wang1
  1. 1Peking University Cancer Hospital & Institute
  2. 2Beijing Cancer Hospital
  3. 3北京大学肿瘤医院

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to March 2023

AbstractFullPdf
Aug 20221100
Sep 20221200
Oct 2022500
Nov 2022400
Dec 2022500
Jan 20231000
Feb 2023800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/MRI and clinical risk factors for early cardiotoxicity induced by anthracycline in patients with malignant tumor
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/MRI and clinical risk factors for early cardiotoxicity induced by anthracycline in patients with malignant tumor
Tingting Yuan, maomao wei, xuetao chen, Xinfeng Lin, Hua Zhu, 志 杨, xuejuan wang
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3367;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/MRI and clinical risk factors for early cardiotoxicity induced by anthracycline in patients with malignant tumor
Tingting Yuan, maomao wei, xuetao chen, Xinfeng Lin, Hua Zhu, 志 杨, xuejuan wang
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3367;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Advantages of rest 18F-FDG myocardial imaging over rest 99mTc-MIBI myocardial perfusion imaging in the diagnosis of obstructive coronary artery disease in Chinese patients with suspected acute coronary syndrome: a prospective real-world clinical study
  • Identifying Successful Coronary Collaterogenesis Using PET Myocardial Perfusion Imaging: Ischemic Zone Coronary Flow Capacity Improves in Patients with Chronic Total Occlusion Treated with External Counter Pulsation
  • Prognostic value of global myocardial flow reserve derived from 99mTc-sestamibi dynamic SPECT in patients with intermediate coronary stenosis
Show more Clinical Science

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire